Tag: Targeted therapy
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy...
Exciting Preclinical Data Shared by Molecular Partners and Orano Med at SNMMI 2024June 11, 2024 01:00 ETMolecular Partners AG and Orano Med have unveiled positive preclinical data for their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate...
Pfizer’s Lung Cancer Drug Is Extending Survival Rates and Stopping Cancer Spread
Pfizer's Lung Cancer Drug Shows Significant Progress in TreatmentKey Takeaways• A recent study revealed that a drug called Lorbrena has shown impressive results in extending survival rates and halting the spread of lung cancer.
•...
Scientists find new method to enhance efficacy of bispecific antibodies for solid tumors
Breakthrough Study Reveals Innovative Approach to Boost Effectiveness of Bispecific Antibodies in Solid Tumor TreatmentA recent study has unveiled a groundbreaking method to enhance the efficacy of bispecific antibody therapies for solid tumors. The...
Ovarian Cancer Drugs Market to Reach USD 9,857 Million by 2032 | Market.us
Ovarian Cancer Drugs Market Projected to Reach USD 9,857 Million by 2032In recent market analysis, the Global Ovarian Cancer Drugs Market is expected to reach a value of USD 9,857 million by the year...